New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users' changing needs—and lets users adjust the settings—has been shown to improve ...

Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users' changing bodies – ...

Navitus, the nation’s first transparent, pass-through pharmacy benefit manager (PBM), released its ninth annual Drug Trend ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of ...

Eating a diet high in phytosterols, found in many plant foods, can reduce the risk of heart disease by 9% and type 2 diabetes ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

A ‘digital twin’ for diabetes control helps users with Type 1 diabetes with UVA-developed artificial pancreases, a new study ...

Current technologies, and those in the pipeline and beyond, could advance the management of diabetes comorbidities, George Grunberger, MD, FACP, FACE, said during a presentation at the Heart in ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

George Medicines announced the FDA approval of its triple therapy polypill for initial treatment of adults with ...